Allison(Paroskie)WheelerMD(She/Her)

Pediatric Anemia and Red Blood Cell Hematology, Pediatric Coagulation Disorder Hematology, Pediatric Platelet Disorder Hematology

Associate Professor

Dr. Wheeler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Vanderbilt University Medical CenterFellowship, Blood Banking/Transfusion Medicine, 2013 - 2014
Vanderbilt UniversityMaster of Science in Clinical Investigation (MSCI), 2011 - 2013
Vanderbilt University Medical CenterFellowship, Pediatric Hematology/Oncology, 2010 - 2013
UMass Chan - BaystateResidency, Pediatrics, 2006 - 2009
University of Massachusetts Medical SchoolClass of 2006

PubMed

38 citations
A cross-sectional analysis of cardiovascular disease in the hemophilia population
Suman L. Sood, Dunlei Cheng, Margaret V. Ragni, Craig M. Kessler, Doris Quon
Blood Advances. 2014-12-06
77 citations
Why factor XI deficiency is a clinical concern
Allison P. Wheeler, David Gailani
Expert Review of Hematology. 2016-06-24
397 citations
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
Isaac See, John R. Su, Allison Lale, Emily Jane Woo, Alice Guh
JAMA. 2021-06-22

Abstracts/Posters

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial
Allison P. Wheeler, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Consistency of Dosing of Turoctocog Alfa Pegol (N8-GP) throughout the Pathfinder Clinical Trials: Implications for Recommendations for Effective Prophylaxis, Bleed Res...
Allison P. Wheeler, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Severe Hemophilia a without Inhibitors: Results from the Phase 2 explorer5 Trial
Allison P Wheeler, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Career-Development Lunch Sessions: Transfusion Medicine
60th American Society of Hematology Annual Meeting - 12/1/2018

Rebinyn Approved in US as Routine Preventive Treatment for Hem BAugust 10th, 2022
Study Launched to Assess Blood Clot Prediction Model for Paediatric PatientsJune 2nd, 2021
Study Validates Predictive Model for Identifying Pediatric Patients at Risk for Developing Blood ClotsMay 19th, 2021
Join now to see all